• +1 700 888 1234

  • Effingerstrasse 40 3008 Bern Switzerland

#WCLC2018 CONCLUSIONS – NELSON STUDY SHOWS CT SCREENING FOR NODULE VOLUME MANAGEMENT REDUCES LUNG CANCER MORTALITY BY 26 PERCENT IN MEN

During the World Congress on Lung Cancer held this year in Toronto, Canada were presented the findings of NELSON study. […]

NEW ESMO TUMOUR DNA SCALE HELPS MATCH PATIENTS WITH CANCER TO OPTIMAL TARGETED MEDICINES

A new scale for tumour DNA mutations which will simplify and standardise choices for targeted cancer treatment has been agreed by […]

LUCE AT ASCO 2018 – LUNG CANCER SCREENING

LuCE members Walce Onlus & Fundacion Mas Que Ideas attended the American Society of Clinical Oncology (ASCO) Annual Meeting. They talked with MD […]

LUCE AT ASCO 2018 – LUNG CANCER HIGHLIGHTS

Prof. Giulio Scagliotti talked about lungcancer highlights with Stefania Vallone, LuCE president and Diego Villalón, LuCE member. Topics focused on new treatment […]

2017 LUCE TRANSLATED REPORT

During latest LuCE Report launching event, Stefania Vallone, LuCE’s President encouraged the attendees to give a step forward, and try […]

PRESENTATION: PATIENT PERSPECTIVE ON LUNG CANCER TREATMENT PROGRESS

Stefania, Vallone, LuCE President, was key note speaker @IASLC Lung Cancer Immunotherapy Meeting, held between March 22-25, 2018 in Barcelona. […]